Trial Profile
A Phase 2 Study Of Perifosine In Metastatic Or Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 May 2007 Status changed from in progress to completed
- 15 Sep 2005 New trial record.